CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Repligen Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Repligen Corp
BUILDING 1, SUITE 100, 41 SEYON STREET
Phone: (302) 658-7581p:302 658-7581 WALTHAM, MA  02453  United States Ticker: RGENRGEN
Business Summary
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2024YesYes--Yes

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8071 Medical laboratories
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Martin D.Madaus 66 3/13/2026 2/6/2023
President, Chief Executive Officer, Director OlivierLoeillot 55 9/1/2024 10/2/2023
Chief Financial Officer Jason K.Garland 51 9/25/2023 9/25/2023
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Repligen GmbH Parkstrabe 10 Ravensburg Germany
Spectrum Laboratories, Inc. 18617 Broadwick Street Rancho Dominguez CA United States
TangenX Technology Corporation 910 Boston Turnpike Road Shrewsbury MA United States

Business Names
Business Name
908 Devices GmbH
ARTeSYN Biosolutions Holdings Ireland Ltd.
ARTeSYN Biosolutions Ireland Limited
18 additional Business Names available in full report.

General Information
Number of Employees: 2,000 (As of 12/31/2025)
Outstanding Shares: 56,331,110 (As of 2/20/2026)
Shareholders: 198
Stock Exchange: NASD
Federal Tax Id: 042729386
Fax Number: (302) 655-5049
Email Address: investors@repligen.com


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 31, 2026